Watkins David, Zuhlke Liesl, Engel Mark, Daniels Rezeen, Francis Veronica, Shaboodien Gasnat, Kango Mabvuto, Abul-Fadl Azza, Adeoye Abiodun, Ali Sulafa, Al-Kebsi Mohammed, Bode-Thomas Fidelia, Bukhman Gene, Damasceno Albertino, Goshu Dejuma Yadeta, Elghamrawy Alaa, Gitura Bernard, Haileamlak Abraham, Hailu Abraha, Hugo-Hamman Christopher, Justus Steve, Karthikeyan Ganesan, Kennedy Neil, Lwabi Peter, Mamo Yoseph, Mntla Pindile, Sutton Chris, Mocumbi Ana Olga, Mondo Charles, Mtaja Agnes, Musuku John, Mucumbitsi Joseph, Murango Louis, Nel George, Ogendo Stephen, Ogola Elijah, Ojji Dike, Olunuga Taiwo Olabisi, Redi Mekia Mohammed, Rusingiza Kamanzi Emmanuel, Sani Mahmoud, Sheta Sahar, Shongwe Steven, van Dam Joris, Gamra Habib, Carapetis Jonathan, Lennon Diana, Mayosi Bongani M
Department of Medicine, Groote Schuur Hospital and University of Cape Town, South Africa; University of Washington, USA.
Department of Medicine, Groote Schuur Hospital and University of Cape Town, South Africa.
Cardiovasc J Afr. 2016;27(3):184-187. doi: 10.5830/CVJA-2015-090. Epub 2016 Jan 12.
Acute rheumatic fever (ARF) and rheumatic heart disease (RHD) remain major causes of heart failure, stroke and death among African women and children, despite being preventable and imminently treatable. From 21 to 22 February 2015, the Social Cluster of the Africa Union Commission (AUC) hosted a consultation with RHD experts convened by the Pan-African Society of Cardiology (PASCAR) in Addis Ababa, Ethiopia, to develop a 'roadmap' of key actions that need to be taken by governments to eliminate ARF and eradicate RHD in Africa. Seven priority areas for action were adopted: (1) create prospective disease registers at sentinel sites in affected countries to measure disease burden and track progress towards the reduction of mortality by 25% by the year 2025, (2) ensure an adequate supply of high-quality benzathine penicillin for the primary and secondary prevention of ARF/RHD, (3) improve access to reproductive health services for women with RHD and other non-communicable diseases (NCD), (4) decentralise technical expertise and technology for diagnosing and managing ARF and RHD (including ultrasound of the heart), (5) establish national and regional centres of excellence for essential cardiac surgery for the treatment of affected patients and training of cardiovascular practitioners of the future, (6) initiate national multi-sectoral RHD programmes within NCD control programmes of affected countries, and (7) foster international partnerships with multinational organisations for resource mobilisation, monitoring and evaluation of the programme to end RHD in Africa. This Addis Ababa communiqué has since been endorsed by African Union heads of state, and plans are underway to implement the roadmap in order to end ARF and RHD in Africa in our lifetime.
急性风湿热(ARF)和风湿性心脏病(RHD)仍是非洲妇女和儿童心力衰竭、中风和死亡的主要原因,尽管它们是可预防且可即时治疗的。2015年2月21日至22日,非洲联盟委员会(非盟委员会)社会事务组在埃塞俄比亚亚的斯亚贝巴主办了一次由泛非心脏病学会(PASCAR)召集的风湿性心脏病专家磋商会,以制定一份政府为在非洲消除急性风湿热和根除风湿性心脏病而需采取的关键行动“路线图”。会议通过了七个优先行动领域:(1)在受影响国家的哨点建立前瞻性疾病登记册,以衡量疾病负担并跟踪到2025年将死亡率降低25%的进展情况;(2)确保有足够的高质量苄星青霉素用于急性风湿热/风湿性心脏病的一级和二级预防;(3)改善患有风湿性心脏病和其他非传染性疾病(NCD)的妇女获得生殖健康服务的机会;(4)下放诊断和管理急性风湿热和风湿性心脏病(包括心脏超声检查)的技术专长和技术;(5)建立国家和区域心脏外科卓越中心,用于治疗受影响患者并培训未来的心血管从业人员;(6)在受影响国家的非传染性疾病控制计划内启动国家多部门风湿性心脏病计划;(7)与跨国组织建立国际伙伴关系,以筹集资源、监测和评估该计划,从而在非洲终结风湿性心脏病。这份亚的斯亚贝巴公报此后得到了非洲联盟国家元首的认可,目前正在制定实施路线图的计划,以便在我们有生之年在非洲终结急性风湿热和风湿性心脏病。